BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Acasti Pharma Announces Closing of $10M Firm Commitment Offering of Common Shares and Warrants

  The Benchmark Company, LLC and Dawson James Securities, Inc. acted as book-running managers for the offering.

  December 27, 2017

   · 

  6 min read
• 

  BioMidwest

  PharMEDium Issues Voluntary Nationwide Recall of Certain Lots of Compounded Sterile Products Due to Lack of Sterility Assurance

  To date, PharMEDium has not received any reports of complaints related to the products but is issuing this recall out of an abundance of caution following a commitment made during a recent inspection of the company’s facility.

  December 27, 2017

   · 

  14 min read
• Policy

  CStone Files CS1003, an Anti-PD-1 Antibody, for Clinical Trial Approval in Australia

  CStone today announced that a formal application for clinical trial approval has been submitted to Human Research Ethics Committees of the Scientia Clinical Research center in Australia for the anti-programmed death-1 (PD-1) mAb candidate CS1003.

  December 27, 2017

   · 

  4 min read
• 

  Biotech Bay

  Theranos Avoids Bankruptcy by Snagging a $100M Lifeline From Fortress

  Many people will be surprised to learn that Theranos is still open and doing business, let alone to be able to acquire a $100M loan.

  December 27, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Shire Plans to Hire in 2018 for its Georgia Manufacturing Site

  The new facility will add about 30 percent more capacity to Shire’s internal network.

  December 27, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics

  It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases.

  December 27, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biotech Beach

  The Number 1 Small-Cap Biotech Investors are Missing Out On

  A look at a small-cap biotech company that investors should consider.

  December 27, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  How This CRISPR Biotech Could Make Investors Rich

  A look at a biotech company that represents a solid trend in the industry.

  December 27, 2017

   · 

  3 min read

   · 

  Mark Terry
• Deals

  Reckitt CEO’s $17B Predicament

  2018 is the year for Rakesh Kapoor to show he’s worth it.

  December 27, 2017

   · 

  1 min read
• Massachusetts’ Taris Biomedical Nabs $25M

  Taris is developing implanted, continuous delivery devices combined with known cancer drugs for bladder disease treatment.

  December 27, 2017

   · 

  1 min read